Clínica Universitaria de Navarra -ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2017

  1. Prognostic value of computed tomography pulmonary angiography indices in patients with cancer-related pulmonary embolism: Data from a multicenter cohort study

    European Journal of Radiology, Vol. 87, pp. 66-75

2013

  1. Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: Results from the ABEL study

    Thrombosis Research, Vol. 132, Núm. 6, pp. 666-670

2009

  1. Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry

    Thrombosis Research, Vol. 124, Núm. 2, pp. 174-177

2008

  1. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms

    Haematologica, Vol. 93, Núm. 5, pp. 729-734

2007

  1. Antithrombin Cambridge II (A384S): An underestimated genetic risk factor for venous thrombosis

    Blood, Vol. 109, Núm. 10, pp. 4258-4263

2002

  1. Prothrombin A19911G and G20210A polymorphisms' role in thrombosis

    British Journal of Haematology, Vol. 118, Núm. 2, pp. 610-614

1997

  1. Trasplante autólogo con esquema BEAM en linfoma

    Sangre, Vol. 42, Núm. SUPPL. 1, pp. 46-49